5-demethoxyubiquinone-9 and beta-resorcylic-acid

5-demethoxyubiquinone-9 has been researched along with beta-resorcylic-acid* in 1 studies

Other Studies

1 other study(ies) available for 5-demethoxyubiquinone-9 and beta-resorcylic-acid

Article	Year
β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in EMBO molecular medicine, 2019, Volume: 11, Issue:1 Coenzyme Q (CoQ) deficiency has been associated with primary defects in the CoQ biosynthetic pathway or to secondary events. In some cases, the exogenous CoQ supplementation has limited efficacy. In the Topics: Animals; Brain; Disease Models, Animal; Energy Metabolism; Histocytochemistry; Hydroxybenzoates; Mice; Mitochondrial Encephalomyopathies; Neuroprotective Agents; Salicylic Acid; Survival Analysis; Treatment Outcome; Ubiquinone	2019

Article

Year

β-RA reduces DMQ/CoQ ratio and rescues the encephalopathic phenotype in

EMBO molecular medicine, 2019, Volume: 11, Issue:1

Coenzyme Q (CoQ) deficiency has been associated with primary defects in the CoQ biosynthetic pathway or to secondary events. In some cases, the exogenous CoQ supplementation has limited efficacy. In the

Topics: Animals; Brain; Disease Models, Animal; Energy Metabolism; Histocytochemistry; Hydroxybenzoates; Mice; Mitochondrial Encephalomyopathies; Neuroprotective Agents; Salicylic Acid; Survival Analysis; Treatment Outcome; Ubiquinone

2019